167 related articles for article (PubMed ID: 18341092)
1. Foot length before and during insulin-like growth factor-I treatment of children with laron syndrome compared to human growth hormone treatment of children with isolated growth hormone deficiency.
Silbergeld A; Lilos P; Laron Z
J Pediatr Endocrinol Metab; 2007 Dec; 20(12):1325-8. PubMed ID: 18341092
[TBL] [Abstract][Full Text] [Related]
2. Head circumference in untreated and IGF-I treated patients with Laron syndrome: comparison with untreated and hGH-treated children with isolated growth hormone deficiency.
Laron Z; Iluz M; Kauli R
Growth Horm IGF Res; 2012 Apr; 22(2):49-52. PubMed ID: 22414926
[TBL] [Abstract][Full Text] [Related]
3. Biphasic response of subscapular skinfold thickness to hGH or IGF-1 administration to patients with congenital IGHD, congenital MPHD and Laron syndrome.
Bisker-Kassif O; Kauli R; Lilos P; Laron Z
Obes Res Clin Pract; 2014; 8(1):e55-62. PubMed ID: 24548577
[TBL] [Abstract][Full Text] [Related]
4. Hand size and growth in untreated and IGF-I treated patients with Laron syndrome.
Konen O; Silbergeld A; Lilos P; Kornreich L; Laron Z
J Pediatr Endocrinol Metab; 2009 Mar; 22(3):235-9. PubMed ID: 19492579
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity).
Laron Z
Pediatr Endocrinol Rev; 2008 Mar; 5(3):766-71. PubMed ID: 18367997
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of hGH and IGF-I on body proportions.
Laron Z; Silbergeld A; Kauli R
Anthropol Anz; 2012 Jul; 69(3):255-9. PubMed ID: 22928349
[TBL] [Abstract][Full Text] [Related]
7. IGF-I replacement therapy in children with congenital IGF-I deficiency (Laron syndrome) maintains heart dimension and function.
Scheinowitz M; Feinberg MS; Laron Z
Growth Horm IGF Res; 2009 Jun; 19(3):280-2. PubMed ID: 19117781
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of GH, IGF-I and insulin on serum sex hormone binding globulin.
Gafny M; Silbergeld A; Klinger B; Wasserman M; Laron Z
Clin Endocrinol (Oxf); 1994 Aug; 41(2):169-75. PubMed ID: 7923821
[TBL] [Abstract][Full Text] [Related]
9. Further observations on the effects of long-term treatment with recombinant human insulin-like growth factor 1 in growth hormone insensitivity syndrome.
El Kholy M; Amr NH; Elsedfy H
Horm Res Paediatr; 2014; 81(4):258-65. PubMed ID: 24642532
[TBL] [Abstract][Full Text] [Related]
10. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
Carvalho LR; de Faria ME; Osorio MG; Estefan V; Jorge AA; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
[TBL] [Abstract][Full Text] [Related]
11. Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II).
Binder G; Iliev DI; Mullis PE; Ranke MB
Growth Horm IGF Res; 2007 Jun; 17(3):242-8. PubMed ID: 17360215
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the growth-promoting effects of insulin-like growth factor I and growth hormone in the early years of life.
Laron Z; Klinger B
Acta Paediatr; 2000 Jan; 89(1):38-41. PubMed ID: 10677055
[TBL] [Abstract][Full Text] [Related]
13. Growth, development, puberty and adult height before and during treatment in children with congenital isolated growth hormone deficiency.
Smuel K; Kauli R; Lilos P; Laron Z
Growth Horm IGF Res; 2015 Aug; 25(4):182-8. PubMed ID: 26077773
[TBL] [Abstract][Full Text] [Related]
14. Response to growth hormone with respect to pubertal status on increased dose in idiopathic growth hormone deficiency: an analysis of Turkish children in the KIGS database (Pfizer International Growth Study).
Darendeliler F; Berberoğlu M; Ocal G; Adiyaman P; Bundak R; Günöz H; Baş F; Darcan S; Gökşen D; Arslanoğlu I; Yildiz M; Ercan O; Ercan G; Ozerkan E; Can S; Böber E; Adal E; Sarikaya S; Dallar Y; Siklar Z; Bircan I; Bideci A; Yüksel B; Büyükgebiz A
J Pediatr Endocrinol Metab; 2005 Oct; 18(10):949-54. PubMed ID: 16355808
[TBL] [Abstract][Full Text] [Related]
15. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
[TBL] [Abstract][Full Text] [Related]
16. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
Ross JL; Lee PA; Gut R; Germak J
Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-I treatment in primary growth hormone insensitivity: effect of recombinant human IGF-I (rhIGF-I) and rhIGF-I/rhIGF-binding protein-3 complex.
Tonella P; Flück CE; Mullis PE
Horm Res Paediatr; 2010; 73(2):140-7. PubMed ID: 20190552
[TBL] [Abstract][Full Text] [Related]
18. Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism.
Laron Z; Anin S; Klipper-Aurbach Y; Klinger B
Lancet; 1992 May; 339(8804):1258-61. PubMed ID: 1349669
[TBL] [Abstract][Full Text] [Related]
19. Muscle force and endurance in untreated and human growth hormone or insulin-like growth factor-I-treated patients with growth hormone deficiency or Laron syndrome.
Brat O; Ziv I; Klinger B; Avraham M; Laron Z
Horm Res; 1997; 47(2):45-8. PubMed ID: 9030966
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
